tiprankstipranks
Trending News
More News >
Rainbow Childrens Medicare Limited (IN:RAINBOW)
:RAINBOW
India Market
Advertisement

Rainbow Childrens Medicare Limited (RAINBOW) Stock Statistics & Valuation Metrics

Compare
0 Followers

Total Valuation

Rainbow Childrens Medicare Limited has a market cap or net worth of ₹152.98B. The enterprise value is ₹142.91B.
Market Cap₹152.98B
Enterprise Value₹142.91B

Share Statistics

Rainbow Childrens Medicare Limited has 101,559,160 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding101,559,160
Owned by Insiders
Owned by Institutions

Financial Efficiency

Rainbow Childrens Medicare Limited’s return on equity (ROE) is 0.17 and return on invested capital (ROIC) is 24.30%.
Return on Equity (ROE)0.17
Return on Assets (ROA)0.10
Return on Invested Capital (ROIC)24.30%
Return on Capital Employed (ROCE)0.33
Revenue Per Employee3.85M
Profits Per Employee617.83K
Employee Count3,940
Asset Turnover0.64
Inventory Turnover14.56

Valuation Ratios

The current PE Ratio of Rainbow Childrens Medicare Limited is 59.4. Rainbow Childrens Medicare Limited’s PEG ratio is ―.
PE Ratio59.4
PS Ratio0.00
PB Ratio0.00
Price to Fair Value9.54
Price to FCF0.00
Price to Operating Cash Flow0.00
PEG Ratio

Income Statement

In the last 12 months, Rainbow Childrens Medicare Limited had revenue of 15.16B and earned 2.43B in profits. Earnings per share was 23.97.
Revenue15.16B
Gross Profit11.15B
Operating Income7.46B
Pretax Income3.30B
Net Income2.43B
EBITDA4.90B
Earnings Per Share (EPS)23.97

Cash Flow

In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00

Dividends & Yields

Rainbow Childrens Medicare Limited pays an annual dividend of ₹3, resulting in a dividend yield of 0.2%
Dividend Per Share₹3
Dividend Yield0.2%
Payout Ratio11.80%
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.25
52-Week Price Change18.42%
50-Day Moving Average1.53K
200-Day Moving Average1.46K
Relative Strength Index (RSI)43.25
Average Volume (3m)5.84K

Important Dates

Rainbow Childrens Medicare Limited upcoming earnings date is Oct 29, 2025, During Market Hours (Confirmed).
Last Earnings DateJul 26, 2025
Next Earnings DateOct 29, 2025
Ex-Dividend DateJun 27, 2025

Financial Position

Rainbow Childrens Medicare Limited as a current ratio of 5.46, with Debt / Equity ratio of 52.01%
Current Ratio5.46
Quick Ratio5.28
Debt to Market Cap<0.01
Net Debt to EBITDA1.52
Interest Coverage Ratio10.29

Taxes

In the past 12 months, Rainbow Childrens Medicare Limited has paid 857.74M in taxes.
Income Tax857.74M
Effective Tax Rate0.26

Enterprise Valuation

Rainbow Childrens Medicare Limited EV to EBITDA ratio is 30.10, with an EV/FCF ratio of 58.98.
EV to Sales9.73
EV to EBITDA30.10
EV to Free Cash Flow58.98
EV to Operating Cash Flow37.27

Balance Sheet

Rainbow Childrens Medicare Limited has ₹5.91B in cash and marketable securities with ₹7.64B in debt, giving a net cash position of ₹1.73B billion.
Cash & Marketable Securities₹5.91B
Total Debt₹7.64B
Net Cash₹1.73B
Net Cash Per Share₹16.99
Tangible Book Value Per Share₹143.38

Margins

Gross margin is 71.52%, with operating margin of 49.18%, and net profit margin of 16.06%.
Gross Margin71.52%
Operating Margin49.18%
Pretax Margin21.77%
Net Profit Margin16.06%
EBITDA Margin32.32%
EBIT Margin23.18%

Analyst Forecast

The average price target for Rainbow Childrens Medicare Limited is ₹1,757.67, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target₹1,757.67
Price Target Upside17.33% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast14.82%
EPS Growth Forecast19.38%

Scores

Smart ScoreN/A
AI Score73
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis